BiosparQ BV

BiosparQ B.V. is a privately-held company dedicated to providing a unique in vitro diagnostics solution for rapid microbial identification called DigiTOF®. DigiTOF® improves patient outcomes, lowers healthcare costs and reduces prescription of antibiotics through enabling clinicians to speed up diagnosis of infections dramatically. The DigiTOF® system is a platform intended for the rapid and cost-effective detection and identification of infectious pathogens direct from patient material. DigiTOF® is based on MALDI-TOF Mass Spectrometry applied on single bacteria isolated directly from patient material. Ease of use, turnaround time of less than 20 minutes and low cost per test will ensure a large variety of applications.

Medical Devices
Alphen Aan Den Rijn, Zuid-Holland
Founded in unknown
11-50 employees

BiosparQ B.V. is a privately-held company dedicated to providing a unique in vitro diagnostics solution for rapid microbial identification called DigiTOF®. DigiTOF® improves patient outcomes, lowers healthcare costs and reduces prescription of antibiotics through enabling clinicians to speed up diagnosis of infections dramatically. The DigiTOF® system is a platform intended for the rapid and cost-effective detection and identification of infectious pathogens direct from patient material. DigiTOF® is based on MALDI-TOF Mass Spectrometry applied on single bacteria isolated directly from patient material. Ease of use, turnaround time of less than 20 minutes and low cost per test will ensure a large variety of applications.

Company Information

Industry
Medical Devices
Company Type
Privately Held
Founded
unknown
Employee Range
11-50
Revenue Range
Not available

Location

Address
Galileiweg 8 South Holland Leiden
City
Alphen Aan Den Rijn
Region
Zuid-Holland
Postal Code
2333
Country
Netherlands

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions